S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.75 (+2.19%)
AAPL   160.10 (+2.10%)
MSFT   336.68 (+2.12%)
FB   338.82 (+1.71%)
GOOGL   2,909.62 (+2.32%)
AMZN   3,568.14 (+1.81%)
TSLA   1,132.46 (+4.67%)
NVDA   333.29 (+5.80%)
BABA   131.58 (-1.33%)
NIO   40.21 (+0.55%)
CGC   11.07 (-5.30%)
AMD   162.32 (+4.85%)
GE   98.57 (+0.75%)
MU   86.13 (+3.25%)
T   23.96 (-1.07%)
F   19.72 (-0.15%)
DIS   147.91 (-0.14%)
ACB   6.43 (-5.30%)
AMC   36.84 (-2.10%)
PFE   52.59 (-2.61%)
BA   197.70 (-0.76%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.75 (+2.19%)
AAPL   160.10 (+2.10%)
MSFT   336.68 (+2.12%)
FB   338.82 (+1.71%)
GOOGL   2,909.62 (+2.32%)
AMZN   3,568.14 (+1.81%)
TSLA   1,132.46 (+4.67%)
NVDA   333.29 (+5.80%)
BABA   131.58 (-1.33%)
NIO   40.21 (+0.55%)
CGC   11.07 (-5.30%)
AMD   162.32 (+4.85%)
GE   98.57 (+0.75%)
MU   86.13 (+3.25%)
T   23.96 (-1.07%)
F   19.72 (-0.15%)
DIS   147.91 (-0.14%)
ACB   6.43 (-5.30%)
AMC   36.84 (-2.10%)
PFE   52.59 (-2.61%)
BA   197.70 (-0.76%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.75 (+2.19%)
AAPL   160.10 (+2.10%)
MSFT   336.68 (+2.12%)
FB   338.82 (+1.71%)
GOOGL   2,909.62 (+2.32%)
AMZN   3,568.14 (+1.81%)
TSLA   1,132.46 (+4.67%)
NVDA   333.29 (+5.80%)
BABA   131.58 (-1.33%)
NIO   40.21 (+0.55%)
CGC   11.07 (-5.30%)
AMD   162.32 (+4.85%)
GE   98.57 (+0.75%)
MU   86.13 (+3.25%)
T   23.96 (-1.07%)
F   19.72 (-0.15%)
DIS   147.91 (-0.14%)
ACB   6.43 (-5.30%)
AMC   36.84 (-2.10%)
PFE   52.59 (-2.61%)
BA   197.70 (-0.76%)
S&P 500   4,655.27 (+1.32%)
DOW   35,135.94 (+0.68%)
QQQ   399.75 (+2.19%)
AAPL   160.10 (+2.10%)
MSFT   336.68 (+2.12%)
FB   338.82 (+1.71%)
GOOGL   2,909.62 (+2.32%)
AMZN   3,568.14 (+1.81%)
TSLA   1,132.46 (+4.67%)
NVDA   333.29 (+5.80%)
BABA   131.58 (-1.33%)
NIO   40.21 (+0.55%)
CGC   11.07 (-5.30%)
AMD   162.32 (+4.85%)
GE   98.57 (+0.75%)
MU   86.13 (+3.25%)
T   23.96 (-1.07%)
F   19.72 (-0.15%)
DIS   147.91 (-0.14%)
ACB   6.43 (-5.30%)
AMC   36.84 (-2.10%)
PFE   52.59 (-2.61%)
BA   197.70 (-0.76%)
OTCMKTS:ERFSF

Eurofins Scientific Stock Forecast, Price & News

$129.75
+14.64 (+12.72%)
(As of 11/26/2021 12:40 PM ET)
Add
Compare
Today's Range
$127.67
▼
$130.28
50-Day Range
$112.00
▼
$146.75
52-Week Range
$71.51
▼
$151.96
Volume
900 shs
Average Volume
1,234 shs
Market Capitalization
$23.10 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.74
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive ERFSF News and Ratings via Email

Sign-up to receive the latest news and ratings for Eurofins Scientific and its competitors with MarketBeat's FREE daily newsletter.


Eurofins Scientific logo

About Eurofins Scientific

Eurofins Scientific SE engages in the bio-analytical testing of food, environment, and pharmaceuticals products. The firm offers testing and laboratory services for agro science, genomics, discovery pharmacology and for supporting clinical studies. It operates through the following geographical segments: Europe, North America, and Rest of the World. The company was founded by Gilles G. Martin in 1987 and is headquartered in Luxembourg.

Headlines

Eurofins Scientific SE (OTCMKTS:ERFSF) Receives Average Recommendation of "Hold" from Brokerages
November 28, 2021 |  americanbankingnews.com
Eurofins Technologies Announces Launch of RT PCR kIts for Rapid Detection of SARS-CoV-2 Variant B.1.1529
November 26, 2021 |  finance.yahoo.com
Eurofins Scientific (OTCMKTS:ERFSF) Stock Price Passes Below 50-Day Moving Average of $127.20
November 19, 2021 |  americanbankingnews.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2021
November 5, 2021 |  finance.yahoo.com
Eurofins Has Entered a Liquidity Contract With Kepler Cheuvreux
October 27, 2021 |  finance.yahoo.com
CORRECTING and REPLACING: Eurofins Eaton Analytical Granted Provisional Approval for UCMR5 Testing
October 27, 2021 |  finance.yahoo.com
Eurofins Responds to Increased Demand For COVID-19 Testing at Schools With Cost-effective Testing Programmes for the Educational Sector
October 19, 2021 |  finance.yahoo.com
Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2021
October 5, 2021 |  finance.yahoo.com
Court Rules in Eurofins Viracor’s favor in Patent Infringement Case
October 1, 2021 |  finance.yahoo.com
Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
September 27, 2021 |  finance.yahoo.com
Eurofins Scientific SE: Transplant Genomics Launches OmniGraf™, the Only Combination Biomarker Panel That Provides the Earliest Indication of Rejection in Kidney Transplant Recipients
September 27, 2021 |  finance.yahoo.com
COVID-19 testing demand sends Eurofins into top French stock market index
September 10, 2021 |  finance.yahoo.com
Eurofins Will Be Included in the CAC 40 Index From September 17
September 10, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ERFSF
Previous Symbol
NASDAQ:ERFSF
CUSIP
N/A
CIK
N/A
Web
www.eurofins.com
Phone
(522) 618-5320
Fax
N/A
Employees
51,516
Year Founded
N/A

Sales & Book Value

Annual Sales
$6.21 billion
Price / Sales
3.72
Cash Flow
$8.19 per share
Price / Cash Flow
15.84
Book Value
$23.85 per share
Price / Book
5.44

Profitability

EPS (Most Recent Fiscal Year)
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.61
Current Ratio
1.37
Quick Ratio
1.28

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
178,000,000
Free Float
N/A
Market Cap
$23.10 billion
Optionable
Not Optionable

Company Calendar

Today
11/29/2021
Fiscal Year End
12/31/2021

MarketRank™

Overall MarketRank™

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Eurofins Scientific (OTCMKTS:ERFSF) Frequently Asked Questions

Is Eurofins Scientific a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last year. There are currently 2 sell ratings, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Eurofins Scientific stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View analyst ratings for Eurofins Scientific or view top-rated stocks.

How has Eurofins Scientific's stock been impacted by COVID-19?

Eurofins Scientific's stock was trading at $495.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ERFSF shares have decreased by 73.8% and is now trading at $129.75.
View which stocks have been most impacted by COVID-19.

Are investors shorting Eurofins Scientific?

Eurofins Scientific saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,099,500 shares, an increase of 60.4% from the October 31st total of 685,400 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 2,748.8 days.
View Eurofins Scientific's Short Interest.

Who are Eurofins Scientific's key executives?

Eurofins Scientific's management team includes the following people:
  • Gilles G. Martin, Chairman & Chief Executive Officer
  • Christian Wurst, Chief Operating Officer-Food & Environment Testing
  • Laurent Lebras, Director-Group Finance & Administration
  • François Vigneau, Managing Director-Food Division Southern Europe

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $129.75.

How much money does Eurofins Scientific make?

Eurofins Scientific has a market capitalization of $23.10 billion and generates $6.21 billion in revenue each year.

How many employees does Eurofins Scientific have?

Eurofins Scientific employs 51,516 workers across the globe.

What is Eurofins Scientific's official website?

The official website for Eurofins Scientific is www.eurofins.com.

Where are Eurofins Scientific's headquarters?

Eurofins Scientific is headquartered at 23 Val Fleuri, Luxembourg N4, 1526.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The company can be reached via phone at (522) 618-5320 or via email at [email protected].


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.